Healthcare Spending Slowdown Sparked Accelerate's Ch. 11
Biotechnology company Accelerate faced regulatory challenges and weakened demand from hospitals for its diagnostics products before it filed for bankruptcy protection this month, and is now planning to sell its assets...To view the full article, register now.
Already a subscriber? Click here to view full article